Intelligence Feed event · Equity · 2026-09-19

    Twist Bioscience Partners With Eli Lilly on TuneLab AI Drug Discovery

    Question

    Twist Bioscience Partners With Eli Lilly on TuneLab AI Drug Discovery

    Direct answer

    Twist Bioscience established a strategic collaboration with Eli Lilly to contribute to the pharmaceutical giant's TuneLab AI platform. Under the agreement, Twist will supply high-throughput antibody characterization data and utilize its AbLab machine-learning model. The contract provides Twist Bioscience with direct fee-for-service revenue while integrating its antibody generation technology into Lilly's computational therapeutic discovery pipeline.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-19
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Twist Bioscience Partners With Eli Lilly on TuneLab AI Drug Discovery”, revision 1, evidence through 2026-09-19. https://marketontology.com/market-events/2026-09-19/twist-bioscience-partners-with-eli-lilly-on-tunelab-ai-drug-discovery-8fd8fb

    EQUITY
    Twist Bioscience Partners With Eli Lilly on TuneLab AI Drug Discovery
    Twist Bioscience established a strategic collaboration with Eli Lilly to contribute to the pharmaceutical giant's TuneLab AI platform. Under the agreement, Twist will supply high-throughput antibody characterization data and utilize its AbLab machine-learning model. The contract provides Twist Bioscience with direct fee-for-service revenue while integrating its antibody generation technology into Lilly's computational therapeutic discovery pipeline.
    TWSTLLY
    Impact
    77
    SEP 19
    SIG
    90%
    TWSTLLY
    Twist Bioscience Partners With Eli Lilly on TuneLab AI Drug Discovery
    Twist Bioscience established a strategic collaboration with Eli Lilly to contribute to the pharmaceutical giant's TuneLab AI platform. Under the agreement, Twist will supply high-throughput antibody characterization data and utilize its AbLab machine-learning model. The contract provides Twist Bioscience with direct fee-for-service revenue while integrating its antibody generation technology into Lilly's computational therapeutic discovery pipeline.
    → Biopharma AI data-service agreements generate high-margin recurring fee revenues and validate TWST's synthetic biology discovery platform.
    Impact
    Twist Bioscience established a strategic collaboration with Eli Lilly to contribute to the pharmaceutical giant's TuneLab AI platform. Under the agreement, Twist will supply high-throughput antibody characterization data and utilize its AbLab machine-learning model. The contract provides Twist Bioscience with direct fee-for-service revenue while integrating its antibody generation technology into Lilly's computational therapeutic discovery pipeline.
    Affected
    TWSTLLY
    Transmission
    Biopharma AI data-service agreements generate high-margin recurring fee revenues and validate TWST's synthetic biology discovery platform.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    TWSTenterprise AI partnership revenue and service margin expansionUp1-4wTWST shares rose over 31% following Lilly TuneLab collaboration announcement.
    LLYbiopharma R&D lead optimization cost reductionUp1-3mIntegration of Twist antibody data into proprietary TuneLab platform.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month